Research on the treatment of autonomic nervous system-related disorders with MSC-CM

Research on the treatment of autonomic nervous system-related disorders with human-derived mesenchymal stem cell conditioned medium

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1051260048

Enrollment

100

Registered

2026-05-13

Start date

2026-03-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autonomic nervous system-related disorders Dysautonomia, Vasovagal syncope, Insomnia, Alopecia

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Individuals who did not experience satisfactory treatment effects with standard therapy. 2. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and whose physicians have determined that treatment with conditioned medium is appropriate. Patients meeting the following criteria are eligible: 1. Individuals aged 18 years or older. 2. Individuals possessing normal consent capacity. 3. Individuals who have been provided with the informed consent document regarding this treatment, have received sufficient explanation, and are capable of providing consent in writing freely and voluntarily. 4. Individuals for whom the attending physician has recognized the necessity of treatment.

Exclusion criteria

Exclusion criteria: Individuals meeting any of the following conditions will be excluded: 1. Users of narcotics or stimulants. 2. Individuals deemed inappropriate by the attending physician.

Design outcomes

Primary

Measure	Time frame
The self-aware symptoms of autonomic nervous system dysfunction and corresponding questioning.	—

Contacts

Public ContactJun Tachibana

Stem Cell Clinic Tokyo

kansaibou.clinic.tokyo@gmail.com+81-362806020

Outcome results